Abbott Laboratories (ABT) Revenue — Quarter Ended Dec 31, 2023
Revenue increased in the quarter compared with both the immediately preceding period and the same period one year earlier. The quarterly performance reversed the pattern of declines seen in the earlier part of the year.
Key takeaway
Quarter ended Dec 31, 2023 · FY2023 Q4
Revenue increased in the quarter compared with both the immediately preceding period and the same period one year earlier. The quarterly performance reversed the pattern of declines seen in the earlier part of the year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$10.2B
Revenue reported for this quarter.
Quarter-over-quarter
+1.0%
Change from the immediately preceding quarter.
Year-over-year
+1.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$40.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2023 | $9.7B | -18.1% |
| Jun 30, 2023 | $10B | -11.4% |
| Sep 30, 2023 | $10.1B | -2.6% |
| Dec 31, 2023 | $10.2B | +1.5% |
Revenue performance
Reported revenue grew from the prior quarter and also rose relative to the same quarter a year ago.
Quarterly comparison
Sequentially, revenue was higher than the preceding quarter. On an annual basis, revenue also exceeded the level of the same quarter one year earlier.
What to watch
The shift from declines to growth in the current quarter is a notable change in the revenue trajectory.